drugset / Trial / NCT00580970
Study of Effectiveness of Lovastatin to Prevent Radiation-Induced Rectal Injury
Phase 2
Completed
73 enrolled
Virginia Commonwealth University
Hunter Holmes Mcguire Veteran Affairs Medical Center · collab
NaSingle-groupOpen-labelSupportive care
Summary
Lovastatin may protect against late effects of radiation therapy in patients with prostate cancer
Timeline
- Start
- 2007-04
- Primary completion
- 2015-08
- Completion
- 2015-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lovastatin | Small molecule | 20 mg | Oral |